
India's booming beauty industry has a serious problem of quality. New rules target this menace
A failure to comply with the new rules introduced by the health and family welfare ministry will result in the suspension and cancellation of licences, according to the officials cited earlier and documents reviewed by Mint.
The Cosmetics (Amendment) Rules, 2025 were finalized and notified on 29 July after a detailed consultative process with the relevant stakeholders and further consultation with the Drugs Technical Advisory Board, a top drug advisory panel, said the first official quoted earlier. The changes include setting up a dedicated Central Cosmetics Laboratory to test products before they hit the shelves.
India's cosmetics market—including skin, hair and oral care, fragrances, and colour products—is estimated at $20 billion, growing at an annualized rate of 25%, according to India Brand Equity Foundation. New brands have been mushrooming as rising incomes spur consumption. However, that also brought a myriad of new products claiming to provide unverified benefits, especially when peddled by celebrities and influencers. Stricter rules aim to curb exaggerated claims and ensure higher standards that will also benefit exports.
"The cosmetic industry in India is largely under-regulated, particularly concerning product claims. Unlike in many other countries, companies here can make unsubstantiated assertions—such as promising to make a person several shades fairer or claiming to stop hair fall—that are often misleading,' said Dr Dinesh Kumar Devaraj, president, Indian Association of Dermatologists, Venereologists & Leprologists (IADVL), Tamil Nadu. 'This is where regulatory checks are critically needed.'
Queries sent to the health ministry spokesperson and cosmetic manufacturers, including Hindustan Unilever Ltd, on Friday remained unanswered.
Cosmetics in India are regulated under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The Central Drugs Standard Control Organization (CDSCO) is the main regulatory body responsible for implementing the rules.
'Lots of clerical and administrative corrections have been made in cosmetics rules,' the first official quoted earlier said. 'These comprehensive measures signal a serious commitment by the government to prioritize consumer safety and bring greater transparency to India's cosmetics industry.'
Manufacturers will now have to keep detailed records of all raw materials and manufactured batches for three years or six months after the batch expires, whichever is later. This improved record-keeping will significantly enhance the traceability of products in case of a safety concern.
The new regulations require that labels on cosmetics to be exported meet the legal standards of the destination country.
A cornerstone of the new policy is the Central Cosmetics Laboratory to test samples. It will also be an appellate laboratory, ensuring a centralized and rigorous approach to product quality.
The rules, for the first time, empower the State Licensing Authority to suspend or cancel a license if a company fails to comply with any of its conditions or with any provision of the Act or the rules. This order will be issued in writing after giving the licencee an opportunity to show cause and be heard. However, a manufacturer whose licence is suspended or cancelled has the right to appeal the decision to the state government within 90 days, ensuring due process is followed.
The new regulations specifically define 'spurious cosmetics' under section 17D of the Act, strengthening the government's ability to crack down on counterfeit items. That provides a stronger legal basis for regulatory bodies to crack down on such items.
The rules also seek to streamline international trade. 'The cosmetic is meant for export, then the label on the package or container of cosmetic shall comply with the law of the country to which the cosmetic is to be exported,' the notification said.
Similarly, a specific provision has been added to allow for a code number instead of the manufacturer's name and address on the label if the importer requires it.
These changes are designed to protect consumers from unsafe and counterfeit cosmetic products while strengthening the regulatory framework, the second official quoted earlier said.
According to the L'Oréal India spokesperson, the updated cosmetic regulations enhance clarity and compliance, '…particularly the provision for export labelling, which significantly streamlines international trade, benefiting our exports from India to 25 countries'. Citing that 95% of its products sold in India are locally manufactured, the spokesperson said these 'progressive changes further support our 'Make in India' endeavors and our mission to provide high-quality beauty solutions both domestically and internationally'.
The industry has also come under scrutiny after complaints regarding mercury-based products, Mint reported earlier. Products such as skin-lightening creams, 'anti-ageing solutions' for freckles and dark spots and certain makeup items are known to contain the toxic element.
Dr. Devaraj said another concern is the misuse of steroids in cosmetics for skin brightening, which can lead to significant dermatological damage. 'As a doctor, I can easily distinguish between skin that has been brightened by such steroid use and skin that is healthy,' he said. 'The issue of wrong or non-existent labelling also needs to be addressed. Furthermore, there is a complete lack of regulation on pricing, which allows for a dramatic disparity in costs for similar products.'
The validation provided by celebrities and social media influencers heavily influences consumers, especially first-time buyers, according to him. 'Given our vast population, a small fraction of buyers can generate significant profit for a company, reducing the need for repeat business,' said Dr. Devaraj. 'This trend has been amplified by the rise in online sales and paid promotions post-Covid.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hindustan Times
5 hours ago
- Hindustan Times
PMC issues show-cause notice to four private hospitals for violation of nursing home norms
The Pune Municipal Corporation (PMC) has issued show-cause notice to four private hospitals in the city for alleged violation of the Bombay Nursing Home Registration Act, 1949, and Maharashtra Nursing Home Registration (Amendment) Rules, 2021, officials said. Dr Sanjay Patil, national secretary, Hospital Board of India, said that the scope of the inspection by the PMC is unclear and needs to be well-defined, including the level at which it should be conducted. (REPRESENTATIVE PHOTO) The PMC issued notice to these hospitals on Tuesday, May 5; they are located in Shivajinagar and Dhankawdi, and were identified during a month-long drive conducted within the PMC limits, officials said. The PMC had started a suo moto inspection of hospitals registered with the civic body in July this year, and as many as 265 such hospitals and nursing homes were inspected. Dr Suryakant Devkar, assistant health officer, PMC, said that the four private hospitals issued notice were allegedly found operating without Nursing Home Act compliance. 'Two hospitals were found operating without a valid fire no-objection certificate (NOC) and complaint book for patients. A couple of hospitals have failed to put up a treatment tariff and patients' charter of rights,' he said. Dr Devkar further informed that the said hospitals have been given a period of one month to complete compliance. 'Post compliance, they have to submit a compliance report to us. The ward medical officers will conduct a reinspection of these hospitals. In case of failure, stringent action will be taken against them as per provisions of the Nursing Home Act,' he said. Whereas Dr Sanjay Patil, national secretary, Hospital Board of India, said that the scope of the inspection by the PMC is unclear and needs to be well-defined, including the level at which it should be conducted. 'Many hospitals have applied for the fire NOC but face technical issues with the online system. If an application is submitted by the hospital, it should be treated as compliance, even if the document is pending. Not all hospitals can display a large number of treatment traffic and patients' charter of rights. Moreover, the PMC must be sensitive when considering the complaints received against private hospitals,' he said. There are as many as 876 nursing homes and hospitals registered with the PMC. The ward medical officers of the PMC conduct inspections, and notices are issued to hospitals found violating the norms. Inspection of all 876 hospitals registered with the PMC will be completed by August, officials said.

The Hindu
9 hours ago
- The Hindu
Long-standing critical vacancies in government hospitals filled through online counselling system in transfers, says Minister Dinesh Gundu Rao
The recent transfer process through a technology-enabled online counselling system in the State Health Department has played a significant role in addressing the issue of long-standing critical vacancies across various public healthcare facilities, particularly in the area of maternal care, said Health Minister Dinesh Gundu Rao. Giving details about the transfer of a total of 5,676 officers and health personnel across the State, carried out under the Karnataka State Civil Services (Regulation of Transfer of Medical Officers and Other Staff) (Amendment) Rules, 2025, Mr. Rao told presspersons that critical positions have been filled in many hospitals, especially in rural areas. Critical triad 'Critical vacancies such as gynaecologists, anesthesiologists and paediatricians — an essential triad for comprehensive maternal health services — have now been filled in a majority of locations. These locations include Community Health Centres (CHCs) in places where the posts were vacant for the last five to seven years,' the Minister said, asserting that the plan is to double this triad in all taluk hospitals in future for further strengthening maternal care. Attributing the success of the initiative to the coordinated efforts of the department at all levels, the Minister said: 'While District Health Officers and their teams diligently compiled and shared data with the State, officials and staff at the State level worked swiftly to consolidate the information and complete the process in record time. A total of 248 teams at the district level and eight teams at the State level operated in video conference mode, ensuring that the transfer process was smooth and efficient.' The annual transfer process in the department has been completed in a record time, commencing on June 19 and concluding by July 3. The technology-enabled online counselling system ensured greater efficiency, speed and reduced human interference, the Minister said. Grievance redressal Besides, a dedicated WhatsApp-based grievance redressal mechanism was introduced, allowing staff to promptly report and resolve any technical or procedural issues. In addition, a new appeal provision in the Transfer Rules, 2025, was introduced to ensure transparency, fairness and timely redressal of grievances during the counselling process. Under this system, appeals are received and disposed of during counselling itself, enabling employees to secure fair opportunities for available postings without waiting until the end of the process. This timely mechanism has not only enhanced employee satisfaction but also strengthened departmental efficiency by reducing delays and disputes, Mr. Rao explained.


Mint
12 hours ago
- Mint
Acko ramps up health insurance play to expand healthcare reach
BENGALURU : Nearly a year after acquiring Better Capital-backed chronic-care startup OneCare, insurtech Acko Technology and Services Pvt. Ltd is doubling down on health insurance offerings, expanding partnerships with hospitals and clinics to tap into the growing opportunity in the space, a top executive told Mint. The Bengaluru-based unicorn acquired the digital chronic-care management company in an all-cash deal in 2024 to enter the health insurance segment. The firm, which began with auto insurance in 2016, is now working on integrating the entire process of buying health insurance—from picking a lab for medical testing to interacting with a hospital for claims. 'The problem in the health insurance industry today is that the burden of the entire process is on the customer. If there's a breakdown in the system, they're on their own. We're working towards integrating the entire system on our app and actually hand-holding customers to pick the best testing labs and hospitals," Animesh Das, managing director and chief executive of Acko General Insurance, told Mint in an interview. Acko aims to capitalize on the booming Indian healthcare sector, which is valued at over $372 billion and is growing at a compound annual growth rate of 21% since 2014, according to estimates by government think tank Niti Aayog. With health premiums already accounting for more than half of Acko's overall premium income, the firm has invested substantially to grow the segment over the last year, Das said. Acko has secured nearly $450 million in funding from investors, including Multiples PE, Accel, Elevation Capital, and General Atlantic. It was last valued at $1.1 billion in October 2021. Last week, cricketer M.S. Dhoni announced his investment in the firm and hopped on board as its brand ambassador. In the healthcare sector, Acko is in direct competition with players such as PharmEasy, HealthQuad-backed HealthifyMe, and HealthPlix that provide healthcare services such as diagnostic tests and doctor consultations. Motor insurance slowdown While Acko is yet to officially file its 2024-25 financials with the Registrar of Companies (RoC), it witnessed 'measured growth" during the year. 'It was a year of learning to know what levers will drive growth for us. Doubling down on health is a product of that learning," Das said. 'Healthcare services are a long-term game for us." The integration of its various insurance services will also result in customers engaging with the platform more regularly, which otherwise tends to be an annual activity. In the fiscal year ended March 2024, Acko's revenue climbed to ₹2,106 crore from ₹1,758 crore in the year prior, filings available with the RoC showed. Its losses narrowed marginally to ₹670 crore from ₹738 crore. Acko is among venture capital firm Elevation Capital's portfolio companies looking to get publicly listed soon. Mint reported on 6 August that the VC firm plans to take at least nine portfolio companies public over the next 12-24 months, as it gears up to monetize its portfolio amid improving public market conditions for tech and consumer startups in the country. Das declined to comment on the IPO timeline. Acko is evolving its model to keep up with a slowdown in the industry. The firm has struck a partnership with American carmaker Tesla Inc. as the insurance partner in India. 'Tesla's branding of a new-age automaker designed for young and aspirational buyers ties in well with the shift in consumer cohorts in our insurance products," Das said. A July Nuvama report said the insurance industry in India is slowing primarily due to moderation in auto sales and a drop in corporate renewal policies. Motor insurance growth has slowed down due to weak retail motor sales. The gross direct premium income (GDPI) in the motor segment rose 6.7% in June 2025, compared to 8.2% in the year-ago period.